MedTech Innovator

MastOR SAS is a medical device company based in Paris, France, founded in 2019. The company focuses on developing a surgical robot designed to assist with laparoscopy, a minimally invasive surgical technique. This innovative platform aims to enhance access to advanced surgical procedures for surgeons and improve resource utilization in operating rooms. By providing tools that facilitate laparoscopy, MastOR seeks to advance surgical practices and patient care.

Indago is a biotechnology company that creates the operating room of the future through smart surgical tools. For surgeons who struggle with cumbersome wires and outdated technology, they built ArthroFree, a fully wireless visualization platform with an attractive cost profile that integrates into existing OR workflows, allowing physicians to focus on patients and procedures, not their tools. The company was founded in 2015 and is headquartered in Cleveland, Ohio, United States.

RevBio is commercializing an injectable, self-setting bone adhesive that can bond bone to bone and bone to metal to stabilize implant devices. Over time, the adhesive biodegrades and is replaced by new bone. This unique material will reduce the duration and complexity of medical procedures, allow for more minimally invasive surgeries, and will improve patient outcomes by reducing recovery time and the overall cost of care.

Bright Uro is an early-stage medical technology company. It is building the next generation of diagnostic devices for Urology. Utilizing advanced hardware, software, and data science can unlock new data streams and offer actionable insight for clinicians.

Endiatx is a medical device manufacturing company that specializes in developing a series of pill-sized robots to perform remote diagnosis. Its unique propulsion system which allows our pill robots to actively navigate the entire length of the GI tract is approximately 30 minutes with real-time video control. It was founded in 2019 and headquartered in Redwood City, California.

Robotic Hospital Nutrition Management Systems

Leadoptik is a California-based company operating in stealth mode, focused on developing advanced miniature imaging technology for minimally invasive medical procedures. This innovative technology enhances surgeons' ability to view small objects with improved clarity compared to existing imaging systems, offering 3D navigation capabilities and high-resolution imaging. By facilitating the early detection of cancer in patients, Leadoptik aims to significantly improve surgical outcomes and patient care.

Pristine Surgical LLC, founded in 2011 and based in Manchester, New Hampshire, has developed a groundbreaking single-use digital imaging platform tailored for surgical and diagnostic rigid endoscopic procedures. The company specializes in single-use digital arthroscopes and laparoscopes that come in a completely sterile kit. By integrating high-definition digital imaging, advanced LED lighting, artificial intelligence, and cloud-based software, Pristine Surgical aims to enhance the efficiency and safety of over 23 million procedures annually. The platform not only improves the surgical experience for patients and healthcare providers but also addresses key concerns such as cost reduction, risk mitigation, and the elimination of cross-contamination associated with reprocessing instruments. Through its innovative technology, Pristine Surgical strives to streamline the entire surgical episode, ultimately improving communication and satisfaction among surgeons and healthcare facilities.

AMB Surgical is a developer of innovative medical devices aimed at treating pediatric deformities, particularly scoliosis. The company has created an electro-mechanical smart automated growing rod known as "FLYTE," which allows for precise and frequent non-surgical adjustments through sensor feedback. This technology enhances the capabilities of surgeons in managing complex cases involving pediatric scoliosis, dynamic external fixation for deformity correction, and applications related to long bone lengthening. By providing a solution that minimizes the need for invasive surgical procedures, AMB Surgical aims to improve treatment outcomes for children facing these conditions.

Auctus Surgical is focused on innovative solutions for treating pediatric scoliosis through its dynamic vertebral body tethering system. This system is designed for non-fusion scoliosis correction, allowing for non-surgical adjustments over time. By incorporating dynamic magnetic technology, Auctus enables surgeons to implement a spinal tethering system that facilitates growth modulation without the need for traditional surgical interventions. In addition to its primary product, Auctus has also licensed technology related to magnetically adjustable growing rods, which can be utilized for both pediatric scoliosis treatment and limb lengthening. This approach aims to improve outcomes for young patients by providing a less invasive alternative to conventional surgical methods.

Deneb Medical is a start-up dedicated to developing a robotic platform for applications in neurosurgery, CMF surgery, head and neck surgery, urology and general surgery.

Deneb Medical is a start-up dedicated to developing a robotic platform for applications in neurosurgery, CMF surgery, head and neck surgery, urology and general surgery.

Osso VR Inc. is a company that develops a virtual reality surgical training platform aimed at enhancing the skills of surgeons, sales teams, and medical trainees across various specialties, particularly orthopedics. Founded in 2016 and based in Palo Alto, California, the company provides an immersive training environment that simulates surgical processes with realistic, haptic-enhanced interactions. This platform facilitates both novice and experienced medical professionals in mastering the latest surgical techniques and instruments through hands-on experiences. Additionally, Osso VR offers analytic dashboards and personalized guidance to further support the learning process, making it a valuable resource in the field of medical education and training.

Eximis Surgical, founded in 2014 and headquartered in Louisville, Colorado, specializes in developing innovative technology for laparoscopic surgery. The company has created a specimen removal device that enables surgeons to efficiently extract large specimens through small incisions. This device utilizes radio frequency (RF) energized cutting wires, which are temporarily held in a containment bag, allowing for quick and safe specimen removal. By integrating seamlessly into existing physician protocols, Eximis Surgical's technology significantly reduces the time required for specimen extraction, minimizes patient discomfort, and ensures safe surgical outcomes. Additionally, the device separates specimens into narrow strips, facilitating the creation of clean tissue segments for accurate pathology identification, thereby enhancing the overall effectiveness of minimally invasive surgery.

Vadovations, Inc. is an Oklahoma City-based company that specializes in the design and manufacture of advanced healthcare equipment, particularly focusing on cardiac assist technologies. Founded in 2009, the company is developing a miniature ventricular assist device (VAD) that is smaller and lighter than existing models. This innovative blood pump allows for less invasive surgical implantation, significantly reducing hospitalization time from three weeks to just four days. The device is engineered for percutaneous delivery and endovascular deployment, minimizing risks associated with traditional blood pumps, such as stroke, bleeding, thrombosis, and infection. By addressing the limitations of current cardiac support systems, Vadovations aims to enhance treatment options for patients with end-stage heart failure while assisting cardiothoracic surgeons and interventional cardiologists in their procedures.

M&S Biotics, LLC is a healthcare technology company based in Scranton, Pennsylvania, established in 2014. It focuses on enhancing the efficiency, efficacy, and safety of surgical procedures through its innovative Biotic Integration system. This system utilizes radio frequency identification (RFID) technology and artificial intelligence to automate the counting of surgical items in real-time, thereby eliminating lengthy inventory protocols. Additionally, the company provides Biotic Insight, an analytics platform that offers valuable data regarding instrument utilization. By streamlining surgical processes, M&S Biotics aims to alleviate the financial pressures faced by hospitals and surgical facilities, enabling them to perform more surgeries annually and ultimately drive revenue growth.

C-SATS provides a personalized surgical skills assessment platform using a unique combination of data analytics, artificial intelligence. It specializes in the fields of robotic surgery, surgical skills, surgical insights, laparoscopic surgery, and minimally invasive surgery. The company was founded in 2014 and headquartered in Seattle, Washington.

Catalia Health Inc. is a San Francisco-based company that develops a cloud-based patient care management platform aimed at enhancing healthcare delivery. Established in 2014, the company integrates artificial intelligence, psychology, and medicine to improve patient engagement and support. Its platform provides healthcare providers with real-time data on patient progress and challenges, facilitating effective communication through mobile apps, web interfaces, and an interactive robotic coach. By delivering tailored conversations to patients, Catalia Health aims to address ongoing healthcare issues, ultimately enabling healthcare professionals to monitor adherence to treatment and improve overall patient outcomes.

Admetsys has developed a first-of-its-kind artificial pancreas for hospital and surgical care, leveraging adaptive learning algorithms and counterbalancing treatment of insulin and glucose. The system has undergone 3 successful FDA-approved clinical trials with 97% control between 80–125 mg/dl and zero incidents of low blood sugar.

Briteseed, LLC is a medical device company based in Chicago, Illinois, specializing in the development and commercialization of advanced surgical technologies. Founded in 2012, the company focuses on creating smart surgical tools that enhance the safety and effectiveness of surgical procedures. Its flagship product, SafeSnips, is a real-time blood vessel detection technology that integrates biosensors into minimally invasive surgical instruments, such as laparoscopic and robotic cutting tools. This technology identifies the presence and size of blood vessels in the surgical area and provides alerts to surgeons through video monitors, thereby improving the precision of surgical operations. Additionally, Briteseed is working on hyperspectral imaging technology that aims to deliver real-time sensing of critical anatomical structures, further enhancing surgical outcomes and patient safety.

Surgisense specializes in the design, development, testing, manufacturing, and marketing of innovative new technologies for medical devices. We focus on developing the next generation of “smart” sensing surgical instruments and medical devices to further enhance surgery, patient care, and patient safety.

Bionic Vision Technologies Pty Ltd is an Australian company focused on developing visual prostheses aimed at restoring vision to individuals affected by blindness, particularly those with inherited retinal diseases. Founded in 2007 and based in Carlton, the company creates a suprachoroidal visual implant system that works by electrically stimulating the remaining retinal cells in patients with retinal degeneration. The innovative devices operate by capturing images through a camera mounted on an eyeglass frame, which are then converted into electrical signals. These signals stimulate the nerves using electrodes placed behind the retina, allowing visual information to be transmitted to the brain. Through this technology, Bionic Vision Technologies seeks to improve the quality of life for blind patients by enhancing their eyesight.

Francis Lamont Innovations (FLI) is an innovative spin-out from an established design / engineering business with a focus on novel electro-mechanical devices to assist surgeons in more effective/less invasive surgical procedures, Our primary product is a novel medical device, the ‘Francis Lamont Orthopaedic Table Extension’ – ‘FLOTE’ – designed to assist surgeons in direct anterior (DAA) hip replacement surgery. FLOTE is a patented device that facilitates and simplifies a difficult ‘minimally invasive’ surgical procedure so that it may be more widely adopted. It is a low-cost, portable device that is designed to greatly exceed the performance of any existing devices at a fraction of the cost. We have proven surgical evidence of the device’s efficacy, as well as patient benefits and outcomes.

Francis Lamont Innovations (FLI) is an innovative spin-out from an established design / engineering business with a focus on novel electro-mechanical devices to assist surgeons in more effective/less invasive surgical procedures, Our primary product is a novel medical device, the ‘Francis Lamont Orthopaedic Table Extension’ – ‘FLOTE’ – designed to assist surgeons in direct anterior (DAA) hip replacement surgery. FLOTE is a patented device that facilitates and simplifies a difficult ‘minimally invasive’ surgical procedure so that it may be more widely adopted. It is a low-cost, portable device that is designed to greatly exceed the performance of any existing devices at a fraction of the cost. We have proven surgical evidence of the device’s efficacy, as well as patient benefits and outcomes.

NovaSignal is a medical technology company commercializing a robotic cerebral ultrasound system. Its Robotic System combines non-invasive ultrasound, robotics, and artificial intelligence to assess real-time cerebral blood flow. Through the use of cloud computing and data analytics, NovaSignal supports physicians in their clinical decision making to help improve patient outcomes. It was founded in 2013 and is headquartered in Los Angeles, California.

Headquartered in Silicon Valley, NeuroSyntek Modeling & Manufacturing is rapidly emerging as a leader in the field of regenerative medicine, a group of biomedical approaches to clinical therapies that involve the use of stem cells to replace or regenerate human cells, tissues or organs to restore or establish normal function. NeuroSyntek is entering human trials on amyotrophic lateral sclerosis (ALS) with a uniquely powerful personalized medicine solution and is able to help with other diseases - such as stroke, brain trauma, Parkinson's, diabetes - to ophthalmology, orthopedic and cosmetic applications. Leveraging their semiconductor platform they bring major cost and automation benefits into stem cell therapy. NeuroSyntek technology allows for autologous mono-phenotype stem-cells cultures to be screened, grown and differentiated for transplantation without the risk of transformation into tumors. They enable this revolutionary approach through the use of their proprietary StemOptimizer platform and behavioral models. This powerful combination allows for unprecedented control over the cellular behavior, in vitro, for precise, automated and continuous cell culture monitoring and manipulation. The StemOptimizer is build around an advanced System-on-Chip architecture and their proprietary silicon extra-cellular sensor. This design allows for an adaptive, dynamically reconfigurable, and able to learn architecture that is the anchor for their aggressive and broad-based product roadmap. Their disruptive technology will help to optimize the massively inefficient $6 trillion healthcare market by dramatically driving down costs and providing effective solutions for stem-cell therapies. In Phase I of their product roadmap they are addressing the $30B+ stem cells market.

LIM Innovations, founded in 2012 by a prosthetist and an orthopedic surgeon, addresses the challenges of traditional prosthetic sockets through innovative design and technology. The company specializes in fully adjustable socket prosthetics tailored for amputees, utilizing 3D digital imaging to create custom-molded devices that fit individual limbs. These modular and adjustable prosthetics are crafted from advanced materials and textiles, enhancing comfort and mobility for users. By integrating insights from the action sports industry, LIM Innovations strives to improve functional outcomes and streamline the prosthetic provisioning process, ultimately enhancing the quality of life for amputees.